https://www.selleckchem.com/pr....oducts/1-methyl-3-ni
We evaluated zonisamide therapy in patients with paroxysmal kinesigenic dyskinesia (PKD). We analyzed zonisamide therapy in 17 patients with PKD at Saitama Children's Medical Center between November 1994 and April 2020. We collected information regarding family history, previous history, age at onset, age at zonisamide commencement, dyskinesia characteristics, brain magnetic resonance imaging, interictal electroencephalography, treatment lag, zonisamide efficacy, zonisamide dose, serum zonisamide concentratio
Respect!
Kommentar
Delen
